Anti-CCL17 antibodies
US9944697B2 · kind B2 · utility
1Cited by
23References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 6, 2014 |
| Grant date | Apr 17, 2018 |
| Priority date | — |
| Expiry date | Nov 6, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to antibodies specifically binding CCL17, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.